Related Experiment Video
Updated: Jun 14, 2026

Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon
Raquel Curtinhas de Lima1, Helver Gonçalves Dias1, Thiara Manuele Alves de Souza1
1Laboratório das Interações Vírus-Hospedeiros, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro 21040-900, Brazil.
Abstract:
Oropouche orthobunyavirus (OROV) is an arbovirus transmitted by midges that has been involved in outbreaks throughout Central and South America. In Brazil, human cases have been historically concentrated in the northern region of the country. Oropouche fever in humans range from mild clinical signs to rare neurological events, and is considered a neglected tropical disease in Brazil. Due to the clinical similarities to other arboviruses, such as chikungunya and dengue viruses, OROV infections are likely to be underreported. Chikungunya virus (CHIKV) cases in Brazil were first recognized in 2014 in the states of Amapá and Bahia in the north and northeast regions, respectively. Both OROV and CHIKV cause nonspecific symptoms, making clinical diagnosis difficult in a scenario of arbovirus cocirculation. Aiming to investigate OROV transmission during the CHIKV introduction in the state of Amapá located in the Brazilian Amazon, we conducted a retrospective molecular (RT-qPCR) and serological investigation in febrile cases (N = 166) collected between August 2014 and May 2015. All acute serum samples were negative for OROV RNA using RT-qPCR. However, neutralizing antibodies for OROV were detected using a plaque reduction neutralization test (PRNT90) in 10.24% (17/166) of the patients, with neutralizing antibody titers ranging from 20 to ≥640, suggesting the previous exposure of patients to OROV. Regarding CHIKV, recent exposure was confirmed by the detection of CHIKV RNA in 20.25% (33/163) of the patients and by the detection of anti-CHIKV IgM in 28.57% (44/154) of the patients. The additional detection of anti-CHIKV IgG in 12.58% (19/151) of the febrile patients suggests that some individuals had been previously exposed to CHIKV. Whether the OROV exposure reported here occurred prior or during the CHIKV circulation in Amapá, is unknown, but because those arboviral infections share similar clinical signs and symptoms, a silent circulation of enzootic arboviruses during the introduction of exotic arboviruses may occur, and highlights the importance of syndromic cases' surveillance to arboviruses in Brazil.
Insights
Oropouche orthobunyavirus (OROV) circulated silently in Brazil’s Amapá state, as indicated by antibody detection during chikungunya virus (CHIKV) introduction. This highlights the need for robust arbovirus surveillance during co-circulation events.
Area of Science:
- Arbovirology
- Epidemiology
- Tropical Medicine
Background:
- Oropouche orthobunyavirus (OROV) causes outbreaks in Central and South America, with underreporting likely due to symptom overlap with other arboviruses like chikungunya virus (CHIKV).
- CHIKV was first identified in Brazil in 2014, presenting diagnostic challenges due to similar non-specific symptoms during arbovirus co-circulation.
- The Brazilian Amazon, specifically the state of Amapá, is a region of interest for arbovirus transmission dynamics.
Purpose of the Study:
- To investigate Oropouche orthobunyavirus (OROV) transmission during the introduction of chikungunya virus (CHIKV) in Amapá, Brazil.
- To assess the co-circulation of OROV and CHIKV in febrile patients using molecular and serological methods.
- To evaluate the diagnostic challenges posed by arboviruses with similar clinical presentations.
Main Methods:
- Retrospective analysis of 166 febrile cases from August 2014 to May 2015 in Amapá, Brazil.
- Molecular detection of OROV and CHIKV RNA using RT-qPCR.
- Serological investigation including plaque reduction neutralization test (PRNT90) for OROV and detection of anti-CHIKV IgM and IgG antibodies.
Main Results:
- No OROV RNA was detected in acute serum samples, indicating no active viral replication during the sampling period.
- Neutralizing antibodies for OROV were found in 10.24% of patients, suggesting prior exposure.
- CHIKV RNA was detected in 20.25% of patients, and anti-CHIKV IgM/IgG antibodies in 28.57%/12.58%, confirming recent and past CHIKV infections.
Conclusions:
- OROV likely had a silent circulation in Amapá prior to or during the CHIKV introduction, evidenced by serological findings.
- The co-circulation of arboviruses with similar symptoms underscores the difficulty in clinical diagnosis and the potential for underreporting.
- Enhanced syndromic surveillance is crucial for detecting enzootic and exotic arboviruses in Brazil, especially during co-circulation events.
Related Concept Videos
Infectious Diseases and Their Occurrence
Chickenpox
Arboviral Encephalitis
Yellow Fever
Leishmaniasis
American Trypanosomiasis

